Read article—Karen Fortuna, an associate professor of community and family medicine, led a study examining early barriers to Medicare’s new peer-support reimbursement codes, including limited awareness, billing complexity, and uncertainty about integrating peer specialists into clinical workflows. The study also found that stakeholders see the codes as a potential way to expand behavioral health access and reduce inappropriate hospitalizations.

Read article—Geisel School of Medicine students are highlighted for leading children’s lessons on how climate change affects human health at New Hampshire Healthy Climate’s Climate Connections and Cafe.

Read article—Nicholas Jacobson, an associate professor of biomedical data science and psychiatry, discusses the challenges of developing mental health benchmarks for AI chatbots, based on his Therabot research. “To actually think about what ‘good’ is, you need to have a standard for how you’re operating, the theoretical lens that you’re bringing to this, and the evidence behind that,” Jacobson said.

Read article—President Sian Leah Beilock and Jennifer Hunt, dean of the Geisel School of Medicine, are featured in coverage of Richard “Dick” Levy ’60’s $20 million gift establishing Dartmouth Health at Home, which will expand home-based care, caregiver support, and training with the goal ofdeveloping a model that can scale nationally. “This is a bet on where healthcare is headed nationally, that we have to help people age successfully in their homes,” Beilock said. (Similar coverage in Yahoo! News, The Conway Daily Sun, and the Laconia Daily Sun via New Hampshire Bulletin)

Read article—President Sian Leah Beilock is quoted in coverage of a $20 million gift from Richard “Dick” Levy ’60 launching Dartmouth Health at Home, a collaboration between Dartmouth Health and the Geisel School ofMedicine to expand home-based care and rural health research. “We are really doubling down on areas where we can have the most impact in terms of our research. And rural health and the ability to deal with rural health disparities is one of our identified areas of impact,” Beilock said. (Similar coverage in Valley News, MyChamplainValley, Modern Healthcare, and Becker’s Health IT.)

Read article—Shane Chapman, a professor of dermatology, is featured discussing the FDA’s approval of Biofrontera’s Ameluz topical gel, the first photodynamic therapy drug approved in the U.S. for skin cancer. “It’s going to be a great FDA-approved option going forward,” particularly for patients who cannot or prefer not to undergo surgery, said Chapman, who was an investigator on the drug’s phase 3 trial.

Read article—Mentions Dartmouth’s Therabot platform as providing significant symptom improvements for people with depression and anxiety in a clinical trial. First author Michael Heinz, an assistant professor of psychiatry, is cited as cautioning that, despite the results, generative AI is not ready to operate independently in mental health care.